TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat. February 6, 2004
TCL Archive In Brief: Henney Names Acting Director Of DRCCA: House Bill Would Slash Deeply Into Research Using Animals September 11, 1981
TCL Archive Federal Budget Cuts Implemented March 1; HHS Agencies Grapple with Consequences March 8, 2013
TCL Archive In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial April 29, 1988
